Disparity in risk factor pattern in premature versus late-onset coronary artery disease: A survey of 15,381 patients

Vascular Health and Risk Management

Volumn 8, Issue 1, 2012, Pages 473-481

  Reibis, Rona ^a,b   Treszl, Andras ^c   Wegscheider, Karl ^c   Bestehorn, Kurt ^d   Karmann, Barbara ^d   Völler, Heinz ^a,e  

^a Rehabilitation Center of Cardiovascular Diseases   (Germany)

^b Kardiologische Gemeinschaftspraxis Am Park Sanssouci Potsdam   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MSD Sharp and Dohme GmbH   (Germany)

^e UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Acute coronary syndrome; Cardiovascular risk factors; Cholesterol; Diabetes; Premature manifestation

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLUCOSE TOLERANCE; HEALTH DISPARITY; HEALTH SURVEY; HEART REHABILITATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; GENETIC PREDISPOSITION; GENETICS; GERMANY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ONSET AGE; PEDIGREE; PREVENTIVE HEALTH SERVICE; PROSPECTIVE STUDY; REGISTER; RISK; SMOKING; STATISTICAL MODEL;

ADULT; AGE OF ONSET; AGED; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; GLUCOSE METABOLISM DISORDERS; HEALTH STATUS DISPARITIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEDIGREE; PREVENTIVE HEALTH SERVICES; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84871878409     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S33305     Document Type: Article

References (48)

1. Franklin BA, Trivax JE, Vanhecke TE. New insights in preventive cardiology and cardiac rehabilitation. Curr Opin Cardiol. 2008;23(5):477-486.
2. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; for EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929-940.
3. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19(10):1434-1503.
4. Yusuf S, Hawken S, Ounpuu S, et al; for INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
5. Department of Noncommunicable Disease Surveillance, World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Part 1. Diagnosis and Classification of Diabetes Mellitus. Report no WHO/NCD/NCS/99.2. Geneva: World Health Organization; 1999.
6. Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil. 2007;14(1):18-27.
7. Schoenenberger AW, Radovanovic D, Stauffer JC, et al; for AMIS Plus Investigators. Acute coronary syndromes in young patients: presentation, treatment and outcome. Int J Cardiol. 2011;148(3):300-304.
8. Heitzer T, Meinertz T. Prevention of coronary heart disease: smoking. Z Kardiol. 2005;94 Suppl 3:III/30-42.German.
9. Grundtvig M, Hagen TP, German M, Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil. 2009;16(2):174-179.
10. Panagiotakos DB, Rallidis LS, Pitsavos C, Stefanadis C, Kremastinos D. Cigarette smoking and myocardial infarction in young men and women: a case-control study. Int J Cardiol. 2007;116(3):371-375.
11. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328(7455):1519.
12. Teo KK, Ounpuu S, Hawken S, et al; for INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(8536):647-658.
13. Van Domburg RT, op Reimer WS, Hoeks SE, Kappetein AP, Bogers AJ. Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study. Am Heart J. 2008;156(3):473-476.
14. Sargent JD, Demidenko E, Malenka DJ, Li Z, Gohlke H, Hanewinkel R. Smoking restrictions and hospitalization for acute coronary events in Germany. Clin Res Cardiol. 2012;101(3):227-235.
15. Hata Y, Nakajima K. Life-style and serum lipids and lipoproteins. J Atheroscler Thromb. 2000;7(4):177-197.
16. Hurrell C, Wietlisbach V, Jotterand V, et al. High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease: the GENECARD project. Atherosclerosis. 2007;194(1):253-264.
17. Andresdottir MB, Sigurdsson G, Sigvaldason H, Gudnason V; for Reykjavik Cohort Study. Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors: the Reykjavik Cohort Study. Eur Heart J. 2002;23(21):1655-1663.
18. Patel MJ, de Lemos JA, Philips B, et al. Implications of family history of myocardial infarction in young women. Am Heart J. 2007; 154(3):454-460.
19. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 2001; 104(4):393-398.
20. Philips B, de Lemos JA, Patel MJ, McGuire DK, Khera A. Relation of family history of myocardial infarction and the presence of coronary arterial calcium in various age and risk factor groups. Am J Cardiol. 2007;99(6):825-829.
21. Warren TY, Barry V, Hooker SP, Sui X, Church TS, Blair SN. Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc. 2010;42(5):879-885.
22. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189-1196.
23. Bartnik M, Rydén L, Malmberg K, et al; for Euro Heart Survey Investigators. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart. 2007;93(1):72-77.
24. Völler H, Reibis R, Pittrow D, et al. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment. Curr Med Res Opin. 2009;25(4):879-890.
25. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334(7588):299-302.
26. Drechsler K, Fikenzer S, Sechtem U, et al. The Euro Heart Survey - Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol. 2008;97(6):364-370.
27. De la Hera JM, Delgado E, Hernández E, et al. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J. 2009;30(21):2614-2621.
28. Lankisch M, Füth R, Schotes D, et al. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol. 2006;95(2):80-87.
29. Knudsen EC, Seljeflot I, Abdelnoor M, et al. Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction: a cohort study on 224 patients. Cardiovasc Diabetol. 2009;8:6-14.
30. Pineda J, Marín F, Marco P, et al. The prognostic value of biomarkers after a premature myocardial infarction. Int J Cardiol. 2010;143(3):249-254.
31. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898-904
32. Erqou S, Kaptoge S, Perry PL, et al; for Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412-423.
33. Clarke R, Peden JF, Hopewell JC, et al; for PROCARDIS Consortium. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518-2528.
34. Pineda J, Marín F, Marco P, et al. Premature coronary artery disease in young (age, 45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers. Int J Cardiol. 2009;136(2):222-225.
35. Bassand JP, Hamm CW, Ardissino D, et al; for Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598-1660.
36. Sarrafzadegan N, Rabiei K, Kabir A, et al. Changes in lipid profile of patients referred to a cardiac rehabilitation program. Eur J Cardiovasc Prev Rehabil. 2008;15(4):467-472.
37. Perk J, De Backer G, Gohlke H, et al; for Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice; European Association for Cardiovascular Prevention and Rehabilitation. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. Epub May 3, 2012.
38. Grundy SM, Brewer HB Jr, Leeman JI, Smith SC Jr, Lenfant C; for American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-448.
39. Baigent C, Keech A, Kearney PM, et al; for Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278.
40. Franklin K, Goldberg RJ, Spencer F, et al; for GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med. 2004;164(13):1457-1463.
41. Rydén L, Standl E, Bartnik M, et al; for Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J. 2007;28(1):88-136.
42. Kannel WB, Vasan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol. 2009;24(4):345-350.
43. Lavie CJ, Milani RV. Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis. 2011;53(6):397-403.
44. Vanhees L, Rauch B, Piepoli M, et al; for EACPR writing group. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III). Eur J Prev Cardiol. Epub May 25, 2012.
45. Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2008;15(3):239-246.
46. Busse R. Disease management programs in Germany's statutory health insurance system. Health Aff (Millwood). 2004;23(3):56-67.
47. Cacoub PP, Zeymer U, Limbourg T, et al; for REACH Registry Investigators. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011;97(8):660-667.
48. EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357(9261):995-1001.